Findings

What do systematic reviews say?

9 questions · 10 findings · 2 reviews · Gut

Sort:Best matchNewest Highest certainty Download CSV

No studies found 6 · 60%GRADE not reported 0 · 0%Very low 4 · 40%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Lactobacillus GG vs placebo

Clinical remission · Patients with acute pouchitis

The review found no eligible studies for this question.

1 finding from 1 review

Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lactobacillus GG vs placebo

Clinical improvement · Patients with acute pouchitis

It is very uncertain whether lactobacillus GG changes clinical improvement compared with placebo (very low certainty).

1 finding from 1 review

Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis 2019 · Cochrane Headline outcomes only
RR 3 [0.14, 65.9]
1 study · 20 participants
Very low

Lactobacillus GG vs placebo

Maintenance of clinical remission · Patients with acute pouchitis

The review found no eligible studies for this question.

1 finding from 1 review

Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lactobacillus GG vs placebo

No episodes of acute pouchitis · Patients with acute pouchitis

The review found no eligible studies for this question.

1 finding from 1 review

Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lactobacillus GG vs placebo

Adverse events · Patients with acute pouchitis

The review found no eligible studies for this question.

1 finding from 1 review

Treatment and prevention of pouchitis after ileal pouch‐anal anastomosis for chronic ulcerative colitis 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Kefir ( Lactobacillus bacteria) vs no intervention

Treatment success as defined by the authors · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Kefir ( Lactobacillus bacteria) vs no intervention

Abdominal pain frequency or change in frequency · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Kefir ( Lactobacillus bacteria) vs no intervention

Pain intensity (measure on a 0‐3 four‐point scale) · people with inflammatory bowel disease

2 findings from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 48 participants
Very low
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Kefir ( Lactobacillus bacteria) vs no intervention

Withdrawals due to adverse events · people with inflammatory bowel disease

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low